Cancer, particularly metastatic cancer, can be added to the list of medical conditions that pose a significant risk of worse COVID-19 outcomes , suggests a new study. Led by Boston Children's Hospital and Zhongnan Hospital ...
May 13, 2020
0
8
As of Wednesday, there's an FDA-approved treatment option besides chemotherapy for people with triple-negative breast cancer that has spread to other parts of the body.
Apr 24, 2020
0
12
Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the progression of the cancer, according to results of a clinical trial led by Mount Sinai researchers ...
Apr 9, 2020
0
4
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St. Michael's ...
Mar 25, 2020
0
100
Advances in treatment have led to the largest yearly declines in deaths due to melanoma ever recorded for this skin cancer, results of a new study suggest.
Mar 19, 2020
0
11
The protein peptidyl arginine deiminase 4 (PAD4), which enables some immune cells to trap bacteria, promoted breast cancer metastasis in mice when expressed in cancer cells, according to data published in Molecular Cancer ...
Mar 19, 2020
0
29
Scientists at UCL have invented a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better ...
Mar 9, 2020
0
149
Researchers at the University of Cincinnati have uncovered a potentially more beneficial treatment regimen for patients with metastatic melanoma.
Feb 26, 2020
0
3
In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that a testosterone-related genetic variant—HSD3B1(1245C) - is associated with more aggressive disease and shorter survival in men with metastatic ...
Feb 13, 2020
0
15
(HealthDay)—For patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) treated with pertuzumab and/or trastuzumab emtansine (T-DM1), a body mass index (BMI) of ≥30 kg/m² ...
Feb 12, 2020
0
1
